维普中文期刊产品整合服务
91篇 您的检索式:作者名="Ardavanis A"
    题名 作者 年代 出处 被引量
1Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer:a phase Ⅲ randomized trial显示文摘Georgoulias V Ardavanis A Tsiafaki X 2005J Clin Oncol2005,23,13:1
2Docetaxel Versus Docetaxel Plus Cisplatin as Front-line Treatment of Patients with Advanced Non-small Lung Cancer:a Randomized,Muhicenter Phase Ⅲ Trial显示文摘 Ardavanis A Agelidou A 2004J Clin Oncol2004,22,13:1
3A nmlticenter ran- domized phase :I trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline-and taxane-pretreated women with metastatic breast cancer显示文摘Pallis AG Boukovinas I Ardavanis A 2012Ann Oncol2012,23,5:1
4Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer显示文摘ARDAVANIS A S IOANNIDIS G N ORPHANOS G S 2006Anticancer Res2006,26,2:1
5Vinorelbine Pluscisplatin versus doeetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase Ⅲ randomized trial 显示文摘Georgoulias V Ardavanis A Tsiafaki X 2005J Clin Oncol2005,23,13:1
6Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer 显示文摘Ardavanis A S Ioannidis G N Orphanos G S 2006Anticancer Res2006,26,2:1
7Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer:a randomized,multicenter phaseⅢtrial显示文摘Georgoulias V Ardavanis A Agelidou A 2004J Clin Oncol2004,22,13:1
8Doeetaxel versus doeetaxel plus cisplatin as first-line treatment of patients with advanced non-small cell lung cancer a randonaized,muhicenter phase Ⅲ trial显示文摘Georgoulias V Ardavanis A Agelidou A 2004J Clin Oneol2004,22,13:1
9Randomized phase Ⅲ trial comparing docetaxel plus epimbicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer显示文摘Mavroudis D Papakotoulas P Ardavanis A 2010Ann Oncol2010,21,1:1
10Vinorebine plus cis- platin versus doeetaxel plus gemeitabine in advanced non-small cell lung cancer : a phase random ized/ral显示文摘Geongoulias V Ardavanis A Tslafaki X 2005J Clin Onco12005,23,13:1
11Randomiz- ed phase trial comparing docetaxel plu epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer显示文摘Mavroudis D Papakotoulas P Ardavanis A 2010Ann Oncol2010,21,1:1
12Vinorelbine plus cispl-atin versus docet axel plus gemcitabine in advanced non-small celllung cancer:a phase 瓜 randomized trial显示文摘Georgoulias V Ardavanis A Tsiafaki X 2005J Clin Oncol2005,23,13:1
13HER-2/neu overexpression in breast cancer:an immunohistochemical study including correlations with clinicopathologic parameters,p53 oncoprotein and cathepsin-D显示文摘Korkolis D Ardavanis A Yotis J 2001Anticancer Res2001,21,:1
14Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first- line treatment in women with advanced breast cancer 显示文摘Mavroudis D Papakotoulas P Ardavanis A 2010Ann Oncol2010,21,1:1
15Erlotinib monotherapy in patients with advanced non-small cell lung cancer: an effective approach with low toxicity 显示文摘Ardavanis A Koumna S Fragos I 2008Anticancer Res2008,28,4:1
16Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non small cell lung cancer:a phase Ⅲ randomized trial显示文摘Georgoulias V Ardavanis A Tsiafaki X 2005J Clin Oncol2005,23,13:1
17Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non- small-cell lung cancer,a phase Ⅲ randomized trial显示文摘Georgoulias V Ardavanis A Tsiafaki X 2005J Clin Oncol2005,23,13:1
18Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer显示文摘Ardavanis A Kountourakis P Kyriakou F 2008Oncologist2008,13,4:1
19HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D 显示文摘Korkolis D Ardavanis A Yotis J 2001Anticancer Res2001,21,3:1
20Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell- lung cancer : a phase Ⅲ randomized trial显示文摘Georgoulias V Ardavanis A Tsiafaki X 2005J Clin Oncol2005,23,13:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费